Does ECULIZUMAB Cause Decreased appetite? 360 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 360 reports of Decreased appetite have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.8% of all adverse event reports for ECULIZUMAB.
360
Reports of Decreased appetite with ECULIZUMAB
0.8%
of all ECULIZUMAB reports
26
Deaths
147
Hospitalizations
How Dangerous Is Decreased appetite From ECULIZUMAB?
Of the 360 reports, 26 (7.2%) resulted in death, 147 (40.8%) required hospitalization, and 8 (2.2%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ECULIZUMAB.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ECULIZUMAB Alternatives Have Lower Decreased appetite Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB